Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted heterocyclic ethers and their use in CNS disorders

Substituted heterocyclic ethers and their use in CNS disorders

US Patent 8026257 · Granted Sep 27, 2011

Estimated economic value: $210,638,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 in2025
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RI2024
Aminotriazolopyridines as kinase inhibitors2024
Indazole carboxamides as kinase inhibitors2024
Biaryl kinase inhibitors2024
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds2024
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds2024
Oxazolidinones as modulators of MGLUR52023
Substituted indole compounds2023
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds2023
5-membered and bicyclic heterocyclic amides as inhibitors of ROCK2023
Indole carboxamide compounds2023